Abstract
Alzheimer’s disease (AD) is a brain disorder associated with a gradual weakening in neurocognitive functions, neuroinflammation, and impaired signaling pathways. Resveratrol (RSV) has neuroprotective properties, but with low bioavailability, and low solubility in vivo. Selenium (Se) is an essential micronutrient for brain function. Thus, this study aimed to evaluate the role of formulated RSV-Se nanoparticles (RSV-SeNPs) on neurochemical and histopathological approaches associated with the AD model in rats induced by Aluminum chloride (AlCl3) at a dose of 100 mg/kg/day for 60 days. RSV-SeNPs supplementation attenuates the impaired oxidative markers and mitochondrial dysfunction. The ameliorative effect of RSV-SeNPs on cholinergic deficits was associated with clearance of amyloid β (Aβ). Furthermore, activation of phosphatidylinositol 3 kinase (PI3K) deactivates glycogen synthase kinase 3 beta (GSK-3β)-mediated tau hyperphosphorylation. Additionally, RSV-SeNPs downregulate signal transducer and activator of transcription (STAT3) expression as well as interleukin-1β (IL-1β) levels, therefore alleviating neuroinflammation in AD. Moreover, RSV-SeNPs upregulate the expression of Sirtuin-1 (SIRT1) and lower that of microRNA-134, consequently increasing neurite outgrowth. Eventually, the obtained results showed that nano-formulation of resveratrol with selenium maximized the therapeutic potential of RSV against Alzheimer’s disease not only by their antioxidant but also by anti-inflammatory effect improving the neurocognitive function and modulating the signaling pathways.
Similar content being viewed by others
Data Availability
All the data are available in the current study.
Abbreviations
- Al:
-
Aluminum
- AD:
-
Alzheimer’s disease
- Aβ:
-
Amyloid β
- MSCs:
-
mesenchymal stem cells
- SIRT:
-
sirtuin
- AlCl3 :
-
aluminum chloride
- MDA:
-
malondialdehyde
- CAT:
-
catalase
- H2O2 :
-
hydrogen peroxide
- GSH:
-
glutathione
- IL-1β:
-
interleukin-1β
- ANOVA:
-
one-way analysis of variance
- LSD:
-
least significant difference
- SE:
-
standard error
- STAT3:
-
signal transducer and activator of transcription
- PI3K:
-
phosphatidylinositol 3 kinase
- GSK3β:
-
glycogen synthase kinase 3 beta
- MiR-134:
-
microRNA- 134
References
Igbokwe IO, Igwenagu E, Igbokwe NA (2019) Aluminium toxicosis: a review of toxic actions and effects. Interdiscip Toxicol 12(2):45–70. https://doi.org/10.2478/intox-2019-0007
Colomina MT, Peris-Sampedro F (2017) Aluminum and Alzheimer’s disease. Adv Neurobiol 18:183–197. https://doi.org/10.1007/978-3-319-60189-2_9
Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7(3):137–152. https://doi.org/10.1038/nrneurol.2011.2
Dilliott AA, Abdelhady A, Sunderland KM et al (2021) Contribution of rare variant associations to neurodegenerative disease presentation. NPJ Genom Med 6(1):80. Published 2021 Sep 28. https://doi.org/10.1038/s41525-021-00243-3
Lin YT, Wu YC, Sun GC, Ho CY, Wong TY, Lin CH, Chen HH, Yeh TC, Li CJ, Tseng CJ, Cheng PW (2018) Effect of resveratrol on reactive oxygen species-induced cognitive impairment in rats with angiotensin II-induced early Alzheimer’s disease †. J Clin Med 7(10):329. https://doi.org/10.3390/jcm7100329
Liu L, Liu Y, Zhao J, Xing X, Zhang C, Meng H (2020) Neuroprotective effects of D-(-)-quinic acid on aluminum chloride-induced dementia in rats. Evid-Based Complement Alternat Med Volume, Article ID 5602597, 10 pages. https://doi.org/10.1155/2020/5602597
ELBini-Dhouib I, Doghri R, Ellefi A, Degrach I, Srairi-Abid N, Gati A (2021) Curcumin attenuated neurotoxicity in sporadic animal model of Alzheimer’s disease. Molecules 26(10):3011. Published 2021 May 18. https://doi.org/10.3390/molecules26103011
Burns J, Yokota T, Ashihar H, Lean ME, Crozier A (2002) Plant foods and herbal sources of resveratrol. J Agric Food Chem 50(11):3337–3340. https://doi.org/10.1021/jf0112973
Malaguarnera G, Pennisi M, Bertino G, Motta M, Borzì AM, Vicari E, Bella R, Drago F, Malaguarnera M (2018) Resveratrol in patients with minimal hepatic encephalopathy. Nutrients 10(3):329. https://doi.org/10.3390/nu10030329
Abedini E, Khodadadi E, Zeinalzadeh E et al (2021) (2021) A comprehensive study on the antimicrobial properties of resveratrol as an alternative therapy. Evid Based Complement Alternat Med 2021:8866311. https://doi.org/10.1155/2021/8866311
Wang D, Li SP, Fu JS, Bai L, Guo L (2016) Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis. Int J Dev Neurosci 49:60–66. https://doi.org/10.1016/j.ijdevneu.2016.01.005
Yang L, Wang W, Chen J, Wang N, Zheng G (2018) A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: inhibiting amyloid β aggregation and reactive oxygen species formation properties. J Biomed Mater Res, Part A 106(12):3034–3041. https://doi.org/10.1002/jbm.a.36493
Ferro C, Florindo HF, Hélder A (2021) Santos Selenium nanoparticles for biomedical applications: from development and characterization to therapeutics. Adv Healthcare Mater 10:2100598. https://doi.org/10.1002/adhm.202100598
Dan L, Zuojia L, Ye Y, Yawen L (2015) Niua F (2015) Green synthesis of gallic acid-coated silver nanoparticles with high antimicrobial activity and low cytotoxicity to normal cells. Process Biochem 50(3):357–366. https://doi.org/10.1016/j.procbio.2015.01.002
Reed L, Muench H (1938) A simple method of estimating fifty percent end points. Am J Hyg 27:493–497
Justin Thenmozhi A, William Raja TR, Manivasagam T, Janakiraman U, Essa MM (2017) Hesperidin ameliorates cognitive dysfunction, oxidative stress and apoptosis against aluminium chloride induced rat model of Alzheimer’s disease. Nutr Neurosci 20(6):360–368. https://doi.org/10.1080/1028415X.2016.1144846
Yoshioka T, Kawada K, Shimada T, Mori M (1979) Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 135(3):372–376. https://doi.org/10.1016/0002-9378(79)90708-7
Sinha AK (1972) Colorimetric assay of catalase. Anal Biochem 47(2):389–394. https://doi.org/10.1016/0003-2697(72)90132-7
Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254. https://doi.org/10.1006/abio.1976.9999
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45. https://doi.org/10.1093/nar/29.9.e45
Kot FS (2019) The effect of natural geochemical background on neurological and mental health. Exposure and Health 12:569–591
Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Khachaturian Snyder PJ, ZS, (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain 141(7):1917–1933. https://doi.org/10.1093/brain/awy132
Fang Y, Ou S, Wu T, Zhou L, Tang H, Jiang M, Xu J, Guo K (2020) Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer’s disease. PeerJ 8:e9308. https://doi.org/10.7717/peerj.9308
Wen Yang, Yue Liu, Qing-Qing Xu, Yan-Fang Xian, Zhi-Xiu Lin (2020) Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K/Akt/GSK-3β pathway in experimental models of Alzheimer’s disease”. Oxid Med Cell Longevity vol. 2020, Article ID 4754195, 17 pages. https://doi.org/10.1155/2020/4754195
Fu Z, Aucoin D, Ahmed M, Ziliox M, Van Nostrand WE, Smith SO (2014) Capping of aβ42 oligomers by small molecule inhibitors. Biochemistry 53(50):7893–7903. https://doi.org/10.1021/bi500910b
Li J, Wuliji O, Li W, Jiang ZG, Ghanbari HA (2013) Oxidative stress and neurodegenerative disorders. Int J Mol Sci 14(12):24438–24475. https://doi.org/10.3390/ijms141224438
Kazuki Y, Iwaharaa N, Hisaharaa S, Emotoc MC, Saitoa T, Suzukia H, Manabea T, Matsumuraa A, Matsushitaa T, Suzukia S, Kawamatad J, Sato-Akabae H, Fujiif HG, Shimohama S (2019) Transplantation of mesenchymal stem cells improves amyloid- pathology by modifying microglial function and suppressing oxidative stress. J Alzheimer’s Dis 72:867–884
Lakshmi BV, Sudhakar M, Prakash KS (2015) Protective effect of selenium against aluminum chloride-induced Alzheimer’s disease: behavioral and biochemical alterations in rats. Biol Trace Elem Res 165(1):67–74. https://doi.org/10.1007/s12011-015-0229-3
Kwon KJ, Kim HJ, Shin CY, Han SH (2010) Melatonin potentiates the neuroprotective properties of resveratrol against beta-amyloid-induced neurodegeneration by modulating AMP-activated protein kinase pathways. J Clin Neurol 6(3):127–137. https://doi.org/10.3988/jcn.2010.6.3.127
Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou P, Martins N, Sharifi-Rad J (2018) Resveratrol: a double-edged sword in health benefits. Biomedicines 6(3):91. https://doi.org/10.3390/biomedicines6030091
Bali P, Lahiri DK, Banik A, Nehru B, Anand A (2017) Potential for stem cells therapy in Alzheimer’s disease: Do neurotrophic factors play critical role? Curr Alzheimer Res 14(2):208–220. https://doi.org/10.2174/1567205013666160314145347
Ramos-Rodriguez JJ, Pacheco-Herrero M, Thyssen D, Murillo-Carretero MI, Berrocoso E, Spires-Jones TL, Bacskai BJ, Garcia-Alloza M (2013) Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice. J Neuropathol Exp Neurol 72(4):272–285. https://doi.org/10.1097/NEN.0b013e318288a8dd
Moorthi P, Premkumar P, Priyanka R, Jayachandran KS, Anusuyadevi M (2015) Pathological changes in hippocampal neuronal circuits underlie age-associated neurodegeneration and memory loss: positive clue toward SAD. Neuroscience 301:90–105. https://doi.org/10.1016/j.neuroscience.2015.05.062
Karthick C, Periyasamy S, Jayachandran KS, Anusuyadevi M (2016) Intrahippocampal administration of ibotenic acid induced cholinergic dysfunction via NR2A/NR2B expression: implications of resveratrol against Alzheimer disease pathophysiology. Front Mol Neurosci 9:28. https://doi.org/10.3389/fnmol.2016.00028
Sadek KM, Lebda MA, Abouzed TK, Nasr SM, Shoukry M (2017) Neuro- and nephrotoxicity of subchronic cadmium chloride exposure and the potential chemoprotective effects of selenium nanoparticles. Metab Brain Dis 32(5):1659–1673. https://doi.org/10.1007/s11011-017-0053-x
Field RH, Gossen A, Cunningham C (2012) Prior pathology in the basal forebrain cholinergic system predisposes to inflammation-induced working memory deficits: reconciling inflammatory and cholinergic hypotheses of delirium. J Neurosci 32(18):6288–6294. https://doi.org/10.1523/JNEUROSCI.4673-11.2012
Kraft AD, Harry GJ (2011) Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int J Environ Res Public Health 8(7):2980–3018. https://doi.org/10.3390/ijerph8072980
Sarlus H, Heneka MT (2017) Microglia in Alzheimer’s disease. J Clin Investig 127(9):3240–3249. https://doi.org/10.1172/JCI90606
Chen S, Dong Z, Cheng M, Zhao Y, Wang M, Sai N, Wang X, Liu H, Huang G, Zhang X (2017) Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke. J Neuroinflammation 14(1):187. https://doi.org/10.1186/s12974-017-0963-x
Chu J, Lauretti E, Praticò D (2017) Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer’s disease. Mol Psychiatry 22(7):1002–1008. https://doi.org/10.1038/mp.2016.214
Hyun-Jung Y (2017) Seong-Ho K (2017) The role of PI3K/AKT pathway and its therapeutic possibility in Alzheimer’s disease. Hanyang Med Rev 37:18–24. https://doi.org/10.7599/hmr.2017.37.1.18
Ahmed T, Javed S, Javed S, Tariq A, Šamec D, Tejada S, Nabavi SF, Braidy N, Nabavi SM (2017) Resveratrol and Alzheimer’s disease: mechanistic insights. Mol Neurobiol 54(4):2622–2635. https://doi.org/10.1007/s12035-016-9839-9
Riba A, Deres L, Sumegi B, Toth K, Szabados E, Halmosi R (2017) Cardioprotective effect of resveratrol in a postinfarction heart failure model. Oxid Med Cell Longev 2017:6819281. https://doi.org/10.1155/2017/6819281
Zhang F, Liu J, Shi JS (2010) Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol 636(1–3):1–7. https://doi.org/10.1016/j.ejphar.2010.03.043
Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53(3):337–351. https://doi.org/10.1016/j.neuron.2007.01.010
Madadi S, Schwarzenbach H, Saidijam M et al (2019) Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease. Cell Biosci 9:91. https://doi.org/10.1186/s13578-019-0354-3
Porquet D, Griñán-Ferré C, Ferrer I, Camins A, Sanfeliu C, Del Valle J, Pallàs M (2014) Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer’s disease. J Alzheimer’s Dis 42(4):1209–1220. https://doi.org/10.3233/JAD-140444
Bastianetto S, Ménard C (1852) Quirion R (2015) Neuroprotective action of resveratrol. Biochem Biophys Acta 6:1195–1201. https://doi.org/10.1016/j.bbadis.2014.09.011
Cao Y, Yan Z, Zhou T, Wang G (2017) SIRT1 regulates cognitive performance and ability of learning and memory in diabetic and nondiabetic models. J Diabetes Res 2017:7121827. https://doi.org/10.1155/2017/7121827
Villemagne VL, Doré V, Bourgeat P, Burnham SC, Laws S, Salvado O, Masters CL, Rowe CC (2017) Aβ-amyloid and tau imaging in dementia. Semin Nucl Med 47(1):75–88. https://doi.org/10.1053/j.semnuclmed.2016.09.006
Cho SH, Chen JA, Sayed F, Ward ME, Gao F, Nguyen TA, Krabbe G, Sohn PD, Lo I, Minami S, Devidze N, Zhou Y, Coppola G, Gan L (2015) SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1β. J Neurosci 35(2):807–818. https://doi.org/10.1523/JNEUROSCI.2939-14.2015
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
The experimental protocol was carried out according to the Guide for the Care and Use of Laboratory Animals (NIH no. 85–23, 1985).
Human and Animal Rights
All the ethical protocols for animal treatment were followed by the National Institutes of Health Guide for the Care and Use of Laboratory Animals and supervised by the animal facilities, National Centre for Radiation Research and Technology, Atomic Energy Authority.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Abozaid, O.A.R., Sallam, M.W., El-Sonbaty, S. et al. Resveratrol-Selenium Nanoparticles Alleviate Neuroinflammation and Neurotoxicity in a Rat Model of Alzheimer’s Disease by Regulating Sirt1/miRNA-134/GSK3β Expression. Biol Trace Elem Res 200, 5104–5114 (2022). https://doi.org/10.1007/s12011-021-03073-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-021-03073-7